Cargando…
Emergency department administration of COVID-19 antibody therapies: Early experience
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934759/ https://www.ncbi.nlm.nih.gov/pubmed/33714645 http://dx.doi.org/10.1016/j.ajem.2021.03.001 |
| _version_ | 1783660877129449472 |
|---|---|
| author | Payette, Christopher Brooks, Joseph T. Shesser, Robert |
| author_facet | Payette, Christopher Brooks, Joseph T. Shesser, Robert |
| author_sort | Payette, Christopher |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7934759 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79347592021-03-05 Emergency department administration of COVID-19 antibody therapies: Early experience Payette, Christopher Brooks, Joseph T. Shesser, Robert Am J Emerg Med Article Elsevier Inc. 2021-11 2021-03-05 /pmc/articles/PMC7934759/ /pubmed/33714645 http://dx.doi.org/10.1016/j.ajem.2021.03.001 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Payette, Christopher Brooks, Joseph T. Shesser, Robert Emergency department administration of COVID-19 antibody therapies: Early experience |
| title | Emergency department administration of COVID-19 antibody therapies: Early experience |
| title_full | Emergency department administration of COVID-19 antibody therapies: Early experience |
| title_fullStr | Emergency department administration of COVID-19 antibody therapies: Early experience |
| title_full_unstemmed | Emergency department administration of COVID-19 antibody therapies: Early experience |
| title_short | Emergency department administration of COVID-19 antibody therapies: Early experience |
| title_sort | emergency department administration of covid-19 antibody therapies: early experience |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934759/ https://www.ncbi.nlm.nih.gov/pubmed/33714645 http://dx.doi.org/10.1016/j.ajem.2021.03.001 |
| work_keys_str_mv | AT payettechristopher emergencydepartmentadministrationofcovid19antibodytherapiesearlyexperience AT brooksjosepht emergencydepartmentadministrationofcovid19antibodytherapiesearlyexperience AT shesserrobert emergencydepartmentadministrationofcovid19antibodytherapiesearlyexperience |